Related Experiment Video
Updated: Sep 29, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Thalidomide in the treatment of leprosy
Steve K Teo1, Ken E Resztak, Michael A Scheffler
1Celgene Corporation, 7 Powder Horn Drive, Warren, NJ 07059, USA. steo@celgene.com
Abstract:
Leprosy is a chronic infection of the skin and nerves caused by Mycobacterium leprae. Erythema nodosum leprosum (ENL) is a reactive state in lepromatous leprosy. Thalidomide has been used to treat ENL since the 1960s. One of its mechanisms of action is anti-inflammatory through selective inhibition of the pro-inflammatory cytokine TNF-alpha produced by monocytes.
Related Concept Videos
Antiprotozoal Agents
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Teratogenicity
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Drugs that Stabilize Microtubules
Drug Therapy
Antianxiety Medications
